All Multiple Sclerosis (MS) reports DelveInsight
All DelveInsight reports Life SciencesPharmaceuticalsDiseases & Conditions Multiple Sclerosis (MS)

Publisher: DelveInsight
Category: Multiple Sclerosis (MS)

Multiple Sclerosis (MS) market research reports by DelveInsight

(22 reports matching your criteria)

    • Multiple Sclerosis - Pipeline Insight, 2024

      Aug 01, 2024  |  Published by: DelveInsight  |  USD 3,000

      Multiple Sclerosis - Pipeline Insight, 2024 DelveInsight’s, “Multiple Sclerosis - Pipeline Insight, 2024” report provides comprehensive insights about 80+ companies and 85+ pipeline drugs in Multiple Sclerosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More

    • Secondary Progressive Multiple Sclerosis (SPMS) – Market Insight, Epidemiology, and Market Forecast – 2034

      Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

      Secondary Progressive Multiple Sclerosis (SPMS) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Secondary Progressive Multiple Sclerosis (SPMS) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Secondary Progres ... Read More

    • Primary Progressive Multiple Sclerosis (PPMS) – Market Insight, Epidemiology, and Market Forecast – 2034

      Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

      Primary Progressive Multiple Sclerosis (PPMS) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Primary Progressive Multiple Sclerosis (PPMS) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Primary Progressive M ... Read More

    • Myelin Regeneration in Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034

      Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

      Myelin Regeneration in Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Myelin Regeneration in Multiple Sclerosis – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Myelin Regeneration in Multip ... Read More

    • Chronic Progressive Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034

      Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

      Chronic Progressive Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Chronic Progressive Multiple Sclerosis – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Chronic Progressive Multiple Sclero ... Read More

    • Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024

      Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

      Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024 DelveInsight’s, “Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Primary Progressive Multiple Sclerosis pipeline landscape. It covers t ... Read More

    • Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2024

      Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

      Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2024 DelveInsight’s, “Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in Relapsing-Remitting Multiple Sclerosis pipeline landscape. It covers ... Read More

    • Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024

      Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

      Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024 Secondary Progressive Multiple Sclerosis (SPMS) Overview ""Secondary Progressive Multiple Sclerosis (SPMS) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario ... Read More

    • Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2024

      Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

      Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2024 Chronic Progressive Multiple Sclerosis Overview ""Chronic Progressive Multiple Sclerosis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across ... Read More

    • Multiple sclerosis - Pipeline Insight, 2024

      Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

      Multiple sclerosis - Pipeline Insight, 2024 DelveInsight’s, “Multiple sclerosis - Pipeline Insight, 2024,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Multiple sclerosis pipeline landscape. It covers the pipeline drug profiles, including clinical and noncli ... Read More

    • Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2024

      Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

      Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2024 Relapsing Multiple Sclerosis (RMS) Overview ""Relapsing Multiple Sclerosis (RMS) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Relapsi ... Read More

    • Walking impairment in Multiple sclerosis Market Insights, Competitive Landscape and Market Forecast–2027

      Jul 01, 2022  |  Published by: DelveInsight  |  USD 2,750

      Walking impairment in Multiple sclerosis Market Insights, Competitive Landscape and Market Forecast–2027 DelveInsight’s ‘Walking impairment in Multiple sclerosis - Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Walking impairment in Mul ... Read More

    • Relapsing Remitting Multiple Sclerosis- Pipeline Insight, 2022

      Mar 01, 2022  |  Published by: DelveInsight  |  USD 2,000

      DelveInsight’s, “ Relapsing Remitting Multiple Sclerosis- Pipeline Insight, 2022 ,” report provides comprehensive insights about 38+ companies and 38+ pipeline drugs in Relapsing Remitting Multiple Sclerosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More

    • Multiple Sclerosis Market Insight, Epidemiology and Market Forecast -2032

      Feb 01, 2022  |  Published by: DelveInsight  |  USD 7,500

      DelveInsight’s " Multiple Sclerosis (MS)–Market Insights, Epidemiology, and Market Forecast–2032 " report deliver an in-depth understanding of the Multiple Sclerosis (MS), historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, an ... Read More

    • Multiple sclerosis - Pipeline Insight, 2022

      Feb 01, 2022  |  Published by: DelveInsight  |  USD 3,000

      DelveInsight’s, “ Multiple sclerosis - Pipeline Insight, 2022 ,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Multiple sclerosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the t ... Read More

    • Multiple Sclerosis - Epidemiology Forecast to 2032

      Feb 01, 2022  |  Published by: DelveInsight  |  USD 3,950

      DelveInsight’s " Multiple Sclerosis–Epidemiology Forecast–2032 " report delivers an in-depth understanding of the Multiple Sclerosis, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Multiple Sclerosis Disease Unders ... Read More

    • Primary Progressive Multiple Sclerosis (PPMS) - Epidemiology Forecast to 2032

      Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

      DelveInsight's "" Primary Progressive Multiple Sclerosis (PPMS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Primary Progressive Multiple Sclerosis (PPMS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, ... Read More

    • Secondary Progressive Multiple Sclerosis (SPMS) - Epidemiology Forecast to 2032

      Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

      DelveInsight's "" Secondary Progressive Multiple Sclerosis (SPMS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Secondary Progressive Multiple Sclerosis (SPMS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spa ... Read More

    • Chronic Progressive Multiple Sclerosis - Epidemiology Forecast to 2032

      Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

      DelveInsight's "" Chronic Progressive Multiple Sclerosis - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Chronic Progressive Multiple Sclerosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, ... Read More

    • Relapsing Multiple Sclerosis (RMS) - Epidemiology Forecast to 2032

      Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

      DelveInsight's "" Relapsing Multiple Sclerosis (RMS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Relapsing Multiple Sclerosis (RMS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the ... Read More

    • Relapsing Multiple Sclerosis (RMS) - Market Insight, Epidemiology and Market Forecast -2032

      Jan 01, 2022  |  Published by: DelveInsight  |  USD 7,500

      DelveInsight's "" Relapsing Multiple Sclerosis (RMS)- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Relapsing Multiple Sclerosis (RMS), historical and forecasted epidemiology as well as the Relapsing Multiple Sclerosis (RMS) market trends ... Read More

    • Walking impairment in Multiple sclerosis Market Insights, Competitive Landscape and Market Forecast–2026

      Jan 01, 2022  |  Published by: DelveInsight  |  USD 4,750

      Walking impairment in Multiple sclerosis Market Insights, Competitive Landscape and Market Forecast–2026 ‘Walking impairment in Multiple sclerosis - Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Walking impairment in Multiple sclerosis ... Read More

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help

Join Alert Me Now!

Receive bi-weekly email alerts on new research

Sign Up

Find out more on our blog
Cookie Settings